Common mental health diagnoses arising from or coinciding with menopausal transition and prescribing of SSRIs/SNRIs medications and other psychotropic medications
Journal of Affective Disorders · 2024-11 · 364 · 259-265
DOI: 10.1016/j.jad.2024.08.036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024-11. Verfasst von Dana Alsugeir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdu…. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors, Psychotropic Drugs, Menopause. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Women with menopausal transition (MT) have an elevated risk of experiencing common mental health diagnoses (CMHD: depression or anxiety). There is no recent data comparing the rate, and treatment, of CMHD between men and women. METHODS: In this population-based study, incidence rates (IR) per 100 person-years-at-risk (PYAR) for men and women ≥45 years registered with an UK primary care practice between 2010 and 2021 were estimated. Incidence rate ratios (IRR) with 95 % confidence intervals (CIs) of CMHD were estimated using men as a reference. We measured first prescriptions for psychotropic medications received within 12 months after CMHD. For selective serotonin reuptake inhibitors (SSRIs) /selective norepinephrine reuptake inhibitors (SNRIs), we measured the IR of prescribing per 100 PYAR, by 10-year bands. Proportion of SSRIs/SNRIs prescribing was estimated per 100 persons. RESULTS: Rates of anxiety and depressive disorders were 1.68 and 1.69 per 100 PYAR in women aged 45-54 years-old compared to 0.91 and 1.20 per 100 PYAR in men, with IRR of 1.84 (95 % CI 1.72-1.97) and 1.44 (1.35-1.53) respectively. SSRIs/SNRIs were the most prescribed medication; in 2021, IRs for SSRIs/SNRIs were 13.4 per 100 PYAR in both sexes. In 2021, the proportion of SSRIs/SNRIs prescribing was 50.67 per 100 women and 41.91 per 100 men. LIMITATIONS: MT is assumed based on women's age as menopause onset is rarely recorded in primary care databases. CONCLUSIONS: Women ≥45 years experienced more CMHD compared to men, especially 45-54 years-olds, which coincides with MT. The proportion of SSRIs/SNRIs prescribing was higher in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Pharmacy Practice Department, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
- Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
- Reproductive Medicine Unit, University College London Hospital, UK.
- Research Department of Practice and Policy, UCL School of Pharmacy, London, UK. Electronic address: r.brauer@ucl.ac.uk.
Zitieren
APA
Alsugeir, D., Adesuyan, M., Talaulikar, V., Wei, L., Whittlesea, C., & Brauer, R. (2024). Common mental health diagnoses arising from or coinciding with menopausal transition and prescribing of SSRIs/SNRIs medications and other psychotropic medications. Journal of Affective Disorders, 364, 259-265. https://doi.org/10.1016/j.jad.2024.08.036
Vancouver
Alsugeir D, Adesuyan M, Talaulikar V, Wei L, Whittlesea C, Brauer R. Common mental health diagnoses arising from or coinciding with menopausal transition and prescribing of SSRIs/SNRIs medications and other psychotropic medications. Journal of Affective Disorders. 2024;364:259-265. doi:10.1016/j.jad.2024.08.036
BibTeX
@article{Alsugeir2024,
author = {Alsugeir, Dana and Adesuyan, Matthew and Talaulikar, Vikram and Wei, Li and Whittlesea, Cate and Brauer, Ruth},
title = {Common mental health diagnoses arising from or coinciding with menopausal transition and prescribing of SSRIs/SNRIs medications and other psychotropic medications},
journal = {Journal of Affective Disorders},
year = {2024},
volume = {364},
pages = {259--265},
doi = {10.1016/j.jad.2024.08.036}
}
EUVIMED